Hospital: Cannabis helped children reduced seizures by 80%

This post is also available in: EspañolChildren with refractory epilepsy reduced their seizures by 80% […]
December 16, 2019

This post is also available in: Español

Children with refractory epilepsy reduced their seizures by 80% after using cannabis oil in a controlled study of Garrahan Hospital in Argentina.

According to the researchers, the results "greatly exceeded expectations."

Upon admission to the protocol, this group of children had an average of 959 crises per month (more than 30 per day), with a minimum of 30 per month and a maximum of 13,200 per month (more than 400 crises per day).

“The numbers are very positive and allow us to see a great reduction in the amount of crisis and improvements in the quality of life. This required study answers a question: Is cannabis oil effective and safe in pharmacologically controlled doses? "Today we know that the answer is yes," says Carlos Kambourian, president of Garrahan Hospital.

Not only the medicine's safety index, but also the response rate was highly successful.

“Of the 49 patients with sufficient follow-up, 39, that is, 80%, had a positive response with reduction in the number of crises. The initial group average of 959 crises per month (about 30 days) decreased to 381 crises per month (13 per day), equivalent to a 60% reduction.

According to these results, the updated treatment that 5 patients were currently free of seizures, and also, dropped 2 out of every three crises a day amongst the others.

“The results confirm what we perceive throughout the treatment with families and patients with refractory epileptic encephalopathies. They are indicators that allow us to understand the importance, efficacy and safety of having this new therapeutic option,” said the principal investigator and head of the Hospital's Neurology Department, Roberto Caraballo.

Study will last another year

In Argentina, 1% of the population suffers from epilepsy. Around 120,000 children, according to Garrahan Hospital, could be benefited from these results, especially the 20% of this population who suffers from serious seizures. 

This research also provides similar results to other research around the world. Argentine researchers reported that their intention was to accurately and without prejudice evaluate the use of cannabidiol (CBD) for seizures before incorporating it as a treatment.

The researchers reported that patients will continue to be incorporated into the study and will be followed up for another year in order to assess that the results are maintained over time.

You can read the statement from Garrahan Hospital at the following link: http://bit.ly/2PNeh30

This post is also available in: Español

Escrito por: Daniel Gomez
Publicado en la revista 
SíGUENOS EN INSTAGRAM COMO @MCNGLOBAL
This error message is only visible to WordPress admins

Error: No connected account.

Please go to the Instagram Feed settings page to connect an account.

Lo más reciente en MCN

También te puede interesar

November 13, 2020
Argentina legalizes the sale of cannabis in pharmacies and home cultivation for therapeutic use

After three years, the Argentine state decides to regulate medical cannabis

Ver Artículo
November 11, 2020
Environmental Commission approves bill to legalize hemp and medicinal cannabis

Legalization of cannabis in Costa Rica could be a reality in the near future

Ver Artículo
October 21, 2020
Mario Cerdas: "In the accusatory piece I am not accused of trafficking cannabis anywhere"

Lawyer Cerdas is not accused of selling or distributing cannabis

Ver Artículo
October 19, 2020
Director of the OIJ on cannabis: "It will be transcendent that the cultivation action is preordered to trafficking to be a crime"

A book written in 2009, the current director of the OIJ, Walter Espinoza proposes that cannabis cultivation is not necessarily a crime

Ver Artículo
Copyright Zegreenlab S.A. Todos los derechos reservados © 2020. Hecho en Costa Rica.
Diseño & Desarrollo por Dbugger Studio
magnifiercrossmenucross-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram